Admission Date:  [**2155-4-19**]              Discharge Date:   [**2155-5-26**]  Date of Birth:  [**2084-1-8**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1505**] Chief Complaint: shortness of breath  Major Surgical or Invasive Procedure: s/p cardiac catheterization on [**4-24**] teeth extractions [**2155-4-28**] redo sternotomy MVR  [**2155-5-5**] (25 mm [**Company 1543**] Mosaic porcine valve) pacemaker  [**2155-5-13**]   History of Present Illness: Pt is 71 yo F with CHF (last EF 50%, severe diastolic dysfunction, h/o multiple exacerbations), DM, HTN, CAD s/p MI, who p/w SOB.
A right fem line was placed.
She was given vanc, CTX, Flagyl, Lasix 60mg IV, Tylenol, ASA, insulin (6U IV, 4U SC), and started on a nitro gtt.
She was also started on IVF at 150cc/hr, as it was thought she was intravascularly dry.
Cath was done [**4-24**] which showed all stents and prio PTCA stents patent with SVG occluded and LIMA to LAD patent.
CAD s/p MI, CABG [**2145**] with occluded grafts, s/p PCI with several stents.
Neck: JVD @ approx 9cm Cardio: RRR, distant heart sounds, [**3-11**] sys m @ LLSB Resp: scattered rhonchi diffusely (both anteriorly and posteriorly), minimal crackles at the bases Abd: soft, nt, nd, +BS Ext: warm.
CHEST (PA & LAT)  [**2155-5-26**] 1:59 PM  CHEST (PA & LAT)  Reason: evaluate for effusion  [**Hospital 93**] MEDICAL CONDITION: 71 year old woman with s/p MVR REASON FOR THIS EXAMINATION: evaluate for effusion TWO VIEW CHEST of [**2155-5-26**].
INDICATION: Evaluate for pleural effusion following mitral valve surgery.
Right internal jugular vascular sheath has been removed and a right PICC line has been placed with tip terminating in the upper superior vena cava.
A permanent pacemaker is unchanged in position, and cardiac and mediastinal contours are stable.
DR. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) 5785**]  PATIENT/TEST INFORMATION: Indication: Mitral valve replacement Height: (in) 64 Weight (lb): 163 BSA (m2): 1.79 m2 BP (mm Hg): 131/32 HR (bpm): 63 Status: Inpatient Date/Time: [**2155-5-21**] at 15:38 Test: TTE (Complete) Doppler: Full Doppler and color Doppler Contrast: None Tape Number: 2007W000-0:00 Test Location: West Echo Lab Technical Quality: Suboptimal     REFERRING DOCTOR: DR. [**First Name (STitle) **] R. [**Doctor Last Name **]  MEASUREMENTS: Left Atrium - Long Axis Dimension: 3.9 cm (nl <= 4.0 cm) Left Atrium - Four Chamber Length: *5.8 cm (nl <= 5.2 cm) Right Atrium - Four Chamber Length: *6.0 cm (nl <= 5.0 cm) Left Ventricle - Septal Wall Thickness: 1.0 cm (nl 0.6 - 1.1 cm)  Left Ventricle - Inferolateral Thickness: 1.1 cm (nl 0.6 - 1.1 cm) Left Ventricle - Diastolic Dimension: 5.3 cm (nl <= 5.6 cm) Left Ventricle - Ejection Fraction: 40% (nl >=55%) Aorta - Valve Level: 2.8 cm (nl <= 3.6 cm) Aorta - Ascending: *3.7 cm (nl <= 3.4 cm) Aortic Valve - Peak Velocity: 1.6 m/sec (nl <= 2.0 m/sec) Mitral Valve - Mean Gradient: 5 mm Hg Mitral Valve - Pressure Half Time: 136 ms Mitral Valve - E Wave: 1.7 m/sec Mitral Valve - A Wave: 1.3 m/sec Mitral Valve - E/A Ratio: 1.31  INTERPRETATION:  Findings:  LEFT ATRIUM: Elongated LA.
A catheter or pacing wire is seen in the RA and extending into the RV.
MITRAL VALVE: Bioprosthetic mitral valve prosthesis (MVR).
A bioprosthetic mitral valve prosthesis is present with normal gradient and mobile leaflets.
She underwent cardiac catheterization on [**4-24**] without intervention (see cath report above).
This was discussed with Dr. [**Last Name (STitle) **] and it was felt to be okay to hold/stop this medication for now as > 1year since most recent stent.
She had episodes post op of overload requiring reintubation once and mask ventilation the second time.
She has had no further episodes and continues to be diuresised aggressively and blood pressure control goal SBP <125.
#Complete heart block - after receiving lopressor went into complete heart block that did not resolving requiring insertion of permanent pacemaker.
CT surgery was consulted for consideration of mitral valve replacement.
They recommended oral surgery consult and teeth extraction on [**4-28**].
She received ampicillin prior to oral surgery.
Mitral Valve replacement was performed on [**5-5**].
# DM:  Continued RISS and home regimen of NPH 22 in AM and 8 in PM and regular insulin 8 in AM and 8 in PM.
Prequired natrecor and lasix for diuresis.
# PPX: ambulating, PPI, bowel regimen .
Medications on Admission: Spironolactone 25 mg qam Furosemide 80 mg [**Hospital1 **] Lisinopril 10mg qam Aspirin 325 mg qd Atorvastatin 80 mg qhs Isosorbide dinitrate 20 mg [**Hospital1 **] Clopidogrel 75 mg qd Folic Acid 1 mg qd Glipizide 10 mg [**Hospital1 **] NPH 22U qam, 8U qpm Reg insulin 8U qam, 8U qpm Quinine Sulfate 260 mg qhs Lopressor 50 mg [**Hospital1 **] Hydralazine 30 mg q6h Sertraline 50 mg qd   Discharge Medications: 1.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 40 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.
Spironolactone 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 80 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: One (1) Subcutaneous twice a day: 18 units sc qam 8 units sc qhs.
Metoprolol Succinate 100 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Captopril 25 mg Tablet Sig: Three (3) Tablet PO TID (3 times a day).
Metolazone 5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Furosemide 80 mg Tablet Sig: One (1) Tablet PO twice a day.
Ferrous Gluconate 300 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Amiodarone 200 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): 400mg daily until [**5-30**] then decrease to 200mg daily to follow up with Dr [**Last Name (STitle) **].
Warfarin 1 mg Tablet Sig: One (1) Tablet PO once a day: goal INR 2.0-2.5 for atrial fibrillation first check [**5-28**] .
Adhere to 2 gm sodium diet no lotions, creams, or powders on any incision no driving for one month no lifting greater than 10 pounds for 10 weeks call for fever greater than 100.5, redness or drainage may shower over incision and pat dry   Followup Instructions: see Dr. [**Last Name (STitle) **] in [**3-8**] weeks   [**Telephone/Fax (1) 2394**] see Dr.[**Last Name (STitle) **] in 4 weeks   [**Telephone/Fax (1) 170**] PT/INR for coumadin dosing first check [**5-28**] goal INR 2.0-2.5    Completed by:[**2155-5-26**
